HR
LMAT icon

Hardy Reed’s LeMaitre Vascular LMAT Stock Holding History

Hardy Reed’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
2,570
+245
+11% +$25.1K 0.02% 220
2026
Q1 		$254K Buy
+2,325
New +$222K 0.02% 212

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hardy Reed's LMAT Position: Q2 2026 in Review

Hardy Reed increased its LeMaitre Vascular (LMAT) stake by 11% in Q2 2026, buying an estimated $25.1K and bringing the position to 2,570 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #220.

Hardy Reed first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $254K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Hardy Reed held 2,570 shares of LeMaitre Vascular worth $247K as of Q2 2026.
  • Hardy Reed bought 245 LeMaitre Vascular shares in Q2 2026, an estimated $25.1K.
  • LeMaitre Vascular made up 0.02% of Hardy Reed's portfolio in Q2 2026, its #220 holding.
  • Hardy Reed first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Hardy Reed's LeMaitre Vascular position peaked at $254K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.